Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes

Reference

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Bedell SL, Goldstein LS, Goldstein AR, et al. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28–37. doi: 10.1016/j.sxmr.2019.09.005.
   PubMed Web of Science ®Google Scholar
• Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8:100170. doi: 10.1016/j.pvr.2019.100170.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393(10167):169–182. doi: 10.1016/S0140-6736(18)32470-X.
   PubMed Web of Science ®Google Scholar
• Zhu K, Deng C, Du P, et al. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo. Reprod Biol Endocrinol. 2022;20(1):50. doi: 10.1186/s12958-022-00921-6.
   PubMed Web of Science ®Google Scholar
• Rahman A, Kobayashi M, Sugimoto K, et al. Reduced claudin-12 expression predicts poor prognosis in cervical cancer. Int J Mol Sci. 2021;22(7):3774. doi: 10.3390/ijms22073774.
   PubMed Web of Science ®Google Scholar
• Al-Saraireh YM, Alshammari F, Youssef AMM, et al. Cytochrome 4Z1 expression is correlated with poor prognosis in patients with cervical cancer. Curr Oncol. 2021;28(5):3573–3584. doi: 10.3390/curroncol28050306.
   PubMed Web of Science ®Google Scholar
• Turashvili G, Wen HY. Multigene testing in breast cancer: what have we learned from the 21-gene recurrence score assay? Breast J. 2020;26(6):1199–1207. doi: 10.1111/tbj.13859.
   PubMed Web of Science ®Google Scholar
• Multhoff G, Hightower LE. Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones. 2011;16(3):251–255. doi: 10.1007/s12192-010-0247-1.
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Gong J. Heat shock proteins promote cancer: it’s a protection racket. Trends Biochem Sci. 2016;41(4):311–323. doi: 10.1016/j.tibs.2016.01.003.
   PubMed Web of Science ®Google Scholar
• Han S, Cheng Z, Zhao X, et al. Diagnostic value of heat shock protein 90alpha and squamous cell carcinoma antigen in detection of cervical cancer. J Int Med Res. 2019;47(11):5518–5525. doi: 10.1177/0300060519865634.
   PubMed Web of Science ®Google Scholar
• Zeng J, He SL, Li LJ, et al. Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway. Mol Med. 2021;27(1):130. doi: 10.1186/s10020-021-00384-2.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu J, Li SZ, et al. Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells. Nan Fang Yi Ke Da Xue Xue Bao. 2016;37(4):475–481.
   PubMedGoogle Scholar
• Medina-Martinez I, Barrón V, Roman-Bassaure E, et al. Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study. PLoS One. 2014;9(5):e97842. doi: 10.1371/journal.pone.0097842.
   PubMed Web of Science ®Google Scholar
• Lee YY, Kim TJ, Kim JY, et al. Genetic profiling to predict recurrence of early cervical cancer. Gynecol Oncol. 2013;131(3):650–654. doi: 10.1016/j.ygyno.2013.10.003.
   PubMed Web of Science ®Google Scholar
• Aolymat I, Hatmal MM, Olaimat AN. The emerging role of heat shock factor 1 (HSF1) and heat shock proteins (HSPs) in ferroptosis. Pathophysiology. 2023;30(1):63–82. doi: 10.3390/pathophysiology30010007.
   PubMedGoogle Scholar
• Ploner A. maCorrPlot: visualize artificial correlation in microarray data. R package version 1.70.0. 2023. Available from: https://www.bioconductor.org/packages/devel/bioc/manuals/maCorrPlot/man/maCorrPlot.pdf
   Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381–5397. doi: 10.1002/sim.5958.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi: 10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi: 10.1089/omi.2011.0118.
   PubMed Web of Science ®Google Scholar
• Chi Y, Xue J, Huang S, et al. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 2019;9(23):6840–6855. doi: 10.7150/thno.36338.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612. doi: 10.1038/ncomms3612.
   PubMed Web of Science ®Google Scholar
• Li Y, Feng J, Wang T, et al. Construction of an immunogenic cell death-based risk score prognosis model in breast cancer. Front Genet. 2022;13:1069921. doi: 10.3389/fgene.2022.1069921.
   PubMed Web of Science ®Google Scholar
• Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955–61. doi: 10.1093/nar/gks1111.
   PubMed Web of Science ®Google Scholar
• Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260.
   PubMed Web of Science ®Google Scholar
• Pei JP, Zhang CD, Yusupu M, et al. Screening and validation of the Hypoxia-Related signature of evaluating tumor immune microenvironment and predicting prognosis in gastric cancer. Front Immunol. 2021;12:705511. doi: 10.3389/fimmu.2021.705511.
   PubMed Web of Science ®Google Scholar
• Arneth B. Tumor microenvironment. Medicina. 2019;56(1):15. doi: 10.3390/medicina56010015.
   PubMed Web of Science ®Google Scholar
• Cogdill AP, Andrews MC, Wargo JA. Hallmarks of response to immune checkpoint blockade. Br J Cancer. 2017;117(1):1–7. doi: 10.1038/bjc.2017.136.
   PubMed Web of Science ®Google Scholar
• Xu Q, Tu J, Dou C, et al. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via thr-328 phosphorylation in hepatocellular carcinoma. Mol Cancer. 2017;16(1):178. doi: 10.1186/s12943-017-0748-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang X, Wang H, et al. Heat shock protein 27 enhances SUMOylation of heat shock protein B8 to accelerate the progression of breast cancer. Am J Pathol. 2020;190(12):2464–2477. doi: 10.1016/j.ajpath.2020.04.012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu W, Wen W, et al. SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis. Front Genet. 2021;12:756094. doi: 10.3389/fgene.2021.756094.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kinoshita T, Nohata N, et al. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. Int J Oncol. 2013;43(6):1855–1863. doi: 10.3892/ijo.2013.2145.
   PubMed Web of Science ®Google Scholar
• Lee AS. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer. 2014;14(4):263–276. doi: 10.1038/nrc3701.
   PubMed Web of Science ®Google Scholar
• Luo C, Qiu J. miR-181a inhibits cervical cancer development via downregulating GRP78. Oncol Res. 2017;25(8):1341–1348. doi: 10.3727/096504017X14867268787969.
   PubMed Web of Science ®Google Scholar
• Yam AY, Xia Y, Lin HT, et al. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat Struct Mol Biol. 2008;15(12):1255–1262. doi: 10.1038/nsmb.1515.
   PubMed Web of Science ®Google Scholar
• Ma J, Yang L, Feng H, et al. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients. J Clin Lab Anal. 2021;35(8):e23793.
   PubMed Web of Science ®Google Scholar
• Li W, Liu J, Zhao H. Prognostic power of a chaperonin containing TCP-1 subunit genes panel for hepatocellular carcinoma. Front Genet. 2021;12:668871. doi: 10.3389/fgene.2021.668871.
   PubMed Web of Science ®Google Scholar
• Hu YX, Zheng MJ, Zhang WC, et al. Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer. J Transl Med. 2019;17(1):379. doi: 10.1186/s12967-019-02140-x.
   PubMed Web of Science ®Google Scholar
• Meng D, Jin H, Zhang X, et al. Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer. Cancer Cell Int. 2021;21(1):362. doi: 10.1186/s12935-021-02073-w.
   PubMed Web of Science ®Google Scholar
• Vallin J, Grantham J. The role of the molecular chaperone CCT in protein folding and mediation of cytoskeleton-associated processes: implications for cancer cell biology. Cell Stress Chaperones. 2019;24(1):17–27. doi: 10.1007/s12192-018-0949-3.
   PubMed Web of Science ®Google Scholar
• Dou L, Zhang X. Upregulation of CCT3 promotes cervical cancer progression through FN1. Mol Med Rep. 2021;24(6):856. doi: 10.3892/mmr.2021.12496.
   PubMed Web of Science ®Google Scholar
• Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol. 2002;2(12):933–944. doi: 10.1038/nri954.
   PubMed Web of Science ®Google Scholar
• Oh DY, Fong L. Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox. Immunity. 2021;54(12):2701–2711. doi: 10.1016/j.immuni.2021.11.015.
   PubMed Web of Science ®Google Scholar
• Han J, Khatwani N, Searles TG, et al. Memory CD8(+) T cell responses to cancer. Semin Immunol. 2020;49:101435. doi: 10.1016/j.smim.2020.101435.
   PubMed Web of Science ®Google Scholar
• Xu F, Zhang F, Wang Q, et al. The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer. BMC Immunol. 2021;22(1):60. doi: 10.1186/s12865-021-00451-7.
   PubMed Web of Science ®Google Scholar
• Lei X, Lei Y, Li JK, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126–133. doi: 10.1016/j.canlet.2019.11.009.
   PubMed Web of Science ®Google Scholar
• Wu K, Lin K, Li X, et al. Redefining Tumor-Associated macrophage subpopulations and functions in the tumor microenvironment. Front Immunol. 2020;11:1731. doi: 10.3389/fimmu.2020.01731.
   PubMed Web of Science ®Google Scholar
• Vagiannis D, Zhang Y, Budagaga Y, et al. Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter. Toxicol Appl Pharmacol. 2022;434:115823. doi: 10.1016/j.taap.2021.115823.
   PubMed Web of Science ®Google Scholar
• Tayyar Y, Idris A, Vidimce J, et al. Alpelisib and radiotherapy treatment enhances alisertib-mediated cervical cancer tumor killing. Am J Cancer Res. 2021;11(6):3240–3251.
   PubMed Web of Science ®Google Scholar